This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Nov 10;54(20):1847-9.

doi: 10.1016/j.jacc.2009.08.013. Epub 2009 Oct 1.

Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure?

PMID: 19800192
DOI: 10.1016/j.jacc.2009.08.013

Free article

Editorial

Is it time to expand the use of cardiac resynchronization therapy to patients with mildly symptomatic heart failure?

Derek V Exner. J Am Coll Cardiol. 2009.

Free article

. 2009 Nov 10;54(20):1847-9.

doi: 10.1016/j.jacc.2009.08.013. Epub 2009 Oct 1.

Author

PMID: 19800192
DOI: 10.1016/j.jacc.2009.08.013

No abstract available

PubMed Disclaimer

Comment on

Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C; REVERSE Study Group. Daubert C, et al. J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1. J Am Coll Cardiol. 2009. PMID: 19800193 Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information